Vestor Capital, LLC Eli Lilly & CO Transaction History

Vestor Capital, LLC

$1.24 Billion
Q2 2024

A detailed history of Vestor Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Vestor Capital, LLC holds 57,800 shares of LLY stock, worth $51.3 Million. This represents 4.22% of its overall portfolio holdings.

Number of Shares

57,800

Previous 40,297 43.43%

Holding current value

$51.3 Million

Previous $31.4 Million 66.93%

% of portfolio

4.22%

Previous 2.65%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $12.7 Million - $15.9 Million	17,503 Added 43.43%	57,800 $52.3 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $2.58 Million - $3.46 Million	4,365 Added 12.15%	40,297 $31.4 Million
Q4 2023 Feb 07, 2024	BUY	$525.19 - $619.13 $490,002 - $577,648	933 Added 2.67%	35,932 $20.9 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $132,583 - $182,786	-305 Reduced 0.86%	34,999 $18.8 Million
Q2 2023 Aug 21, 2023	BUY	$350.74 - $468.98 $10.2 Million - $13.6 Million	29,055 Added 464.95%	35,304 $16.6 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $5.74 Million - $7.68 Million	-16,373 Reduced 72.38%	6,249 $2.14 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $5.6 Million - $6.57 Million	-18,021 Reduced 44.34%	22,622 $7.77 Million
Q1 2023 Apr 26, 2023	SELL	$310.63 - $364.82 $4.76 Million - $5.59 Million	-15,315 Reduced 27.37%	40,643 $3.74 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $4.4 Million - $5.13 Million	13,689 Added 32.39%	55,958 $20.5 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $6.95 Million - $7.92 Million	-23,448 Reduced 35.68%	42,269 $13.7 Million
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $88,357 - $103,744	-317 Reduced 0.48%	65,717 $21.3 Million
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $2.65 Million - $3.29 Million	11,283 Added 20.61%	66,034 $18.9 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $35,751 - $44,367	159 Added 0.29%	54,751 $15.1 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $25,262 - $31,088	-114 Reduced 0.21%	54,592 $12.6 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $470,513 - $608,605	-2,606 Reduced 4.55%	54,706 $12.6 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $95,141 - $123,164	579 Added 1.02%	57,312 $10.7 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $3,131 - $4,143	24 Added 0.04%	56,733 $9.58 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $1.38 Million - $1.6 Million	9,440 Added 19.97%	56,709 $8.39 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $5.54 Million - $6.86 Million	46,558 Added 6548.24%	47,269 $6.56 Million
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $23,950 - $29,664	-224 Reduced 23.96%	711 $93,000
Q3 2019 Nov 20, 2019	BUY	$106.79 - $116.16 $99,848 - $108,609	935 New	935 $104,000

Others Institutions Holding LLY

# of Institutions

3,871

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $843B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestor Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vestor Capital, LLC with notifications on news.

Account

Vestor Capital, LLC Eli Lilly & CO Transaction History